News for ImmunoGen, Inc. (IMU.DE)

AstraZeneca Plc and Daiichi's breast cancer drug Enhertu is based off of Daiichi's antibody-drug conjugate platform DXd, and was the top-selling ADC globally in 2023

Anti-tumor clinical responses were observed in 29% (4/14) of efficacy-evaluable patients with PROC treated with TransCon IL-2 β/γ in combination with...

Advancements and Projections in the Antibody Drug Conjugates Market: Insights, Trends, Opportunities, and Recent Developments...

The IDH inhibitors market is expected to grow significantly in the coming years. This is due to the rising occurrence of IDH-mutated cancers, such as acute...

Insights from Maverick Capital's Latest 13F Filing

Insights from Maverick Capital's Latest 13F Filing Lee Ainslie (Trades, Portfolio), the founder and CEO of Maverick Capital, has once again made notable change

The Global Ovarian Cancer Treatment Drugs Market Size was Valued at USD 2.50 Billion in 2023 and the Worldwide Ovarian Cancer Treatment Drugs Market Size...

Drug blockbusters facing key patent expirations and Big Pharma's surplus of cash suggest increased M&A volume in the coming year. Click here to read our picks.

Biotech M&A activity surged at the end of 2023, which helped small biotech sector surge. Find out 3 logical buyout targets in biotech/biopharma space in 2024.

Operator: Good afternoon. We will begin the MacroGenics 2023 Fourth Quarter Corporate Progress and Financial Results Conference Call in just a moment.

NEW YORK, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential...

NEW YORK, Dec. 8, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC , a national securities firm rated Top 50 in the 2018-2022...

Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results.

U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday.

Technological advancements and development in cancer treatment, extensive Research & Development (R&D) in novel drug therapeutics, and increasing use of...

In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.

Discover how our Advanced cash covered put selling strategy can help you generate high yields while minimizing market risk. Click for our exclusive picks.

/PRNewswire/ -- The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2023 Prix Galien...

The acute myeloid leukemia market has a promising outlook with emerging therapies. The overall dynamics of the acute myeloid leukemia market are...